Diseminación hematógena y neumonitis por el bacilo de Calmette-Guérin

Yossepowitch, 2006, Safety and efficacy of intravesical bacillus Calmette-Guerin instillations in steroid treated and immunocompromised patients, J Urol, 176, 482, 10.1016/j.juro.2006.03.066 Cobas Paz, 2010, Tuberculosis miliar por BCG en un paciente asintomático: ¿afectación inicial o una entidad no descrita?, Arch Bronconeumol, 46, 394, 10.1016/j.arbres.2010.01.003 Lamm, 2000, Efficacy and safety of bacille Calmette-Guerin immunotherapy in superficial bladder cancer, Clin Infect Dis, 31, S86, 10.1086/314064 Heiner, 2008, Effect of advance age on the development of complications from intravesical bacillus Calmette-Guerin therapy, Urol Oncol, 26, 137, 10.1016/j.urolonc.2007.04.005 González, 2003, Spectrum of bacille Calmette-Guerin infection after intravesical BCG immunotherapy, Clin Infect Dis, 36, 140, 10.1086/344908 O’Donnell MA. Complications of intravesical BCG immunotherapy. En: UpToDate on line 2011. Gómez-Ferrer Lozano, 2006, Neumonitis granulomatosa por instilación endovesical de BCG, Actas Uro Esp, 30, 839, 10.1016/S0210-4806(06)73544-6 Steg, 1989, Systemic bacillus Calmette-Guerin infection in patients treated by intravesical BCG therapy for superficial bladder cancer, Prog Clin Biol Res, 310, 325